Parabens Effects on Estrogenic Receptors of C13 Cell Line Chemometrics in Simultaneous Spectrophotometric Determination
Iranian Journal of Pharmaceutical Sciences,
Vol. 9 No. 3 (2013),
1 July 2013
,
Page 29-36
https://doi.org/10.22037/ijps.v9.40871
Abstract
Ovarian cancer is one of the major causes of death in women. Parabens are a class of chemicals widely used as preservatives in cosmetic and pharmaceutical products, they mimic estrogens, which are known to play a role in the development of different cancers in women. The Aim of this study was to investigate the proliferative effects of Methyl Paraben (MP) and Propyl Paraben (PP) on human ovarian adenocarcinoma C13 cell line.C13 cell line grown in phenol red-free RPMI 1640, supplemented with 10% NCS, were exposed to either 0-100 μM of estradiol (E)or tamoxifen (T). After 5 days, the number of live cells in each well (12 well plate) was counted using trypan blue assay to obtain the EC50 or LC50 of E and T using the regression fitness analysis on GraphPad Prism© software. The acquired EC50 for E was used for MP and PP exposure, alone or in a co-treatment with LC50 of T to investigate their effects on C13 growth curve.LC50 and EC50 of T and E were 3.125 μg/ml and 12.5 μg/ml, respectively. In a co-administration of these two, T showed to be a good cell growth inhibitor for the first 9 days, when the proliferative effect of estrogenic compounds lead to cell mitosis. Parabens showed estradiol pattern boost in cell growth for the first 8 days, but had more sustained and powerful proliferative effect compared to estradiol with a 300% increase in cell number on day 10. In co-administration with T, MP and E reversed T inhibitory effects from the beginning with MP boosting cell proliferation up to 500% on day 10.Both MP and PP showed delayed proliferative effects much stronger than E on C13 cells. MP was the most potent growth stimulating paraben on C13 cells with a rank order of MP>PP>E. It is concluded that parabens are much toxic in human than thought before, but with a delayed toxicity pattern. More investigation on chronic uses of paraben containing products is required for the safety measurement of these compounds.
- MethylParaben
- PropylParaben
- Estradiol
- Tamoxifen
- Growth Curve
- C13 cell line
How to Cite
References
[2] Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Gaitskell, Hermon C, Moser K, Reeves G, Peto R. Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol. 2012; 13(9):946-956. Epub 2012 Aug 3.
[3] Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev. 2009;18(1):132-139.
[4] Steinberg, D.C., 2005 Preservatives Use: Frequency Report and Registration, Cosmetics & Toiletries,121(7), 65-69 (2006).
[5] Elder, R.L. , et al., Final Report on the Safety Assessment of Methylparaben, Ethylparaben, Propylparaben, and Butylparaben, Journal of the American College of Toxicology, 3(5), 147-209 (1984).
[6] Cashman, A. &Warshaw, E. Parabens: structure, formulation and metabolism. Dermatitis, 16 (2), Retrieved from http: //www. medscape. com/ view article/ 508430_2, 2005.
[7] Darbre PD. J ApplToxicol. ―Underarm cosmetics and breast cancer,‖ 2003 Mar-Apr;23(2):89-95.
[8] Harvey P.W., Everett D.J. "Significance of the detection of esters of p-hydroxybenzoic acid (parabens)in human breast tumours". Journal of Applied Toxicology 2004, 24 (1): 1–4. doi:10.1002/jat.957).
[9] Crinnion WJ. Toxic effects of the easily avoidable phthalates and parabens. Environmental Medicine, Southwest College of Naturopathic Medicine, Tempe, AZ, USA. Altern Med Rev. 2010 Sep; 15(3):190-6.
[10] Darbre, P. D., Bayford, J. R., Shaw, L. E., Horton, R. A. and Sauer, M. J. (2002) Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol., 22, 219–226.
[11] Oishi, S. Effects of butyl paraben on the male productive system in rats. Toxicol. Ind. Health, (2001) 217, 31–39.
[12] Oishi, S. Effects of propyl paraben on the male productive system. Food Chem. Toxicol., (2002) 40,1807–1813.
[13] Mark G et al. the health controversies of Parabens. Skin therapy letter. (2013) 18 (2).
[14] Renata S. T, Fatima C. M, Paulo J. O, João R, Francisco P. P. Parabens in male infertility—Is there a mitochondrial connection? Reproductive Toxicology. 27 (2009) 1–7.
[15] Satoh, K., Nagai, F., Aoki, N. and Nishijima, M. (2000) Competitive binding of some alkyl p-hydroxybenzoates to human estrogen receptor α and β. J. Pharm. Soc. Jpn., 120, 1429–1433.
[16] Bayford, J. R., Shaw, L. E., Drew, M. G. B., Pope,G. S., Sauer, M. J. and Darbre, P. D. (2002) Oestro-genic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biol. Mol. Biol., 80, 49–60.
[17] Anna W, Ewa L.G. Effects of single and repeated in vitro exposure of three forms of parabens, methyl-, butyl- and propylparabens on the proliferation and estradiol secretion in MCF-7 and MCF-10A cells.Pharmacological Reports. 2013, 65, 484-493.
- Abstract Viewed: 251 times
- IJPS_Volume 9_Issue 3_Pages 29-36 Downloaded: 186 times